The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Purpose
Sponsors of certain medical devices are required to submit annual reports for the first three years of inclusion in the Australian Register of Therapeutic Goods (ARTG). The submission of annual reports is part of the device lifecycle approach for the sponsor to demonstrate that:
- high risk devices that are new to the Australian market continue to meet the Essential Principles for safety and performance; and
- the manufacturer’s post-market surveillance system can identify any safety or performance issues or signals associated with the device as early as possible.
If you are a sponsor of a medical device that is:
- an implantable Class IIb device; or
- a Class III device; or
- an Active Implantable Medical Device (AIMD) (now Class III devices); or
- a Class 4 in vitro diagnostic (IVD) device
then one of your automatic post-market obligations is to provide three consecutive annual reports to us after your device is included in the ARTG. The details are referenced in Regulation 5.11 of the Therapeutic Goods (Medical Devices) Regulations 2002.